The University of Texas M.D. Anderson Cancer Center GI Medical Oncology Dept
The University of Texas M.D. Anderson Cancer Center GI Medical Oncology Dept
Houston, Texas, United States1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC) | Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC) | Recruiting | Phase 2 | 2026-08-12 | NCT06589440 |